BioSpace News Archive

Deals

Cipher Pharmaceuticals and Cardiome Pharma Announce Strategic Transaction for Canadian Business Portfolio of Cardiome

Cipher Pharmaceuticals and Cardiome Pharma Corp. announced their entry into a definitive arrangement agreement pursuant to which Cipher will acquire the Canadian business portfolio of Cardiome.

March 20, 2018
·
8 min read
Genetown

Nexcelom Bioscience announces strategic growth investment from Ampersand Capital Partners

Nexcelom Bioscience, a leading provider of cell counting and analysis products for biomedical research and the biopharma industry, announced today that it has received a strategic investment from Ampersand Capital Partners.

March 20, 2018
·
3 min read
Pharm Country

Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin® Injection

Mitomycin for Injection is available to Mylan’s hospital and other institutional customers.

March 20, 2018
·
3 min read
Drug Development

Antibe Therapeutics Announces Successful Phase 2B Gastrointestinal Safety Study for Lead Pain Drug, ATB-346

The double-blind study was conducted in 244 healthy volunteers and was designed to demonstrate the superiority of ATB-346 in GI safety compared to naproxen.

March 20, 2018
·
6 min read
FDA

Exactech’s Vitamin E Acetabular Polyethylene Liner for Hip Replacement Gains FDA 510(k) Clearance

Clearance from the U.S. Food and Drug Administration (FDA) to market the Novation XLE Vitamin E acetabular polyethylene liners for hip replacement surgery.

March 20, 2018
·
1 min read
Business

Truveris Appoints Sally Welborn, former head of Walmart Global Benefits to Board of Directors

Brings deep industry experience to the leading pharmaceutical data analytics firm focused on providing everyone with greater access to affordable medications

March 20, 2018
·
2 min read
Business

MellingMedical Awarded Federal Supply Contract for Pharmaceuticals

Expanding Business to Enhance Access and Care to Pharmaceutical Products

March 20, 2018
·
1 min read
Biotech Beach

Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock

Arena Pharmaceuticals, Inc. announced that it intends to offer and sell, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering.

March 20, 2018
·
2 min read
Business

Arrowhead Pharmaceuticals Reports Inducement Grants To Six New Employees under NASDAQ Marketplace Rule 5635(c)(4)

Arrowhead Pharmaceuticals, Inc. announced that as an inducement to entering into employment with the Company, on March 16, 2018, the Board of Directors approved “inducement” grants to six new employees.

March 20, 2018
·
1 min read
Business

Biotech Big Bangs Its Way Into New York City Via Beacon Capital’s Incubator

Beacon Capital released the introduction of a unique NYC incubator initiative “Beacon Pharma.

March 20, 2018
·
1 min read